Yes. Ultragenyx Pharmaceutical (RARE) passes the AAOIFI Shari’ah Standard 21 screen.
Yes. Ultragenyx Pharmaceutical (RARE) passes the Catholic screen based on the USCCB investment guidelines.
Yes. Ultragenyx Pharmaceutical (RARE) passes the Biblically Responsible Investing (BRI) screen.